Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
151 |
|
Actual shortage: | 5 (3%) | |
Anticipated shortage: | 2 (1%) | |
Avoided shortage: | 4 (3%) | |
Resolved: | 140 (93%) | |
Discontinuation Reports |
51 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 51 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-08-29 | 2023-01-17 | 168148 |
AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-27 | 54440 |
AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2020-02-04 | 2020-04-17 | 105259 |
FLAREX | 0.1% | SUSPENSION | Resolved | 2017-07-13 | 2017-07-27 | 15722 |
EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Resolved | 2019-12-03 | 2020-03-09 | 100125 |
TEGRETOL CR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-02 | 2017-12-13 | 27924 |
PATADAY | 0.2% | SOLUTION | Resolved | 2019-05-07 | 2019-06-19 | 83364 |
TRIESENCE | 40MG | SUSPENSION | Resolved | 2018-10-23 | 2018-11-07 | 65471 |
TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-01-25 | 2019-03-13 | 73545 |
TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-05-07 | 2020-09-08 | 83368 |
TRIESENCE | 40MG | SUSPENSION | Resolved | 2021-06-04 | 2022-01-04 | 140457 |
ARZERRA | 100MG | SOLUTION | Resolved | 2017-03-23 | 2018-10-17 | 4096 |
ARZERRA | 1000MG | SOLUTION | Resolved | 2017-03-23 | 2018-09-27 | 4093 |
ILEVRO | 0.3% | SUSPENSION | Resolved | 2018-08-24 | 2018-12-13 | 58947 |
ILEVRO | 0.3% | SUSPENSION | Resolved | 2022-06-09 | 2022-10-17 | 162289 |
ILEVRO | 0.3% | SUSPENSION | Resolved | 2023-04-13 | 2023-05-19 | 189506 |
DUREZOL | 0.05% | EMULSION | Resolved | 2018-04-18 | 2018-04-20 | 46280 |
DUREZOL | 0.05% | EMULSION | Resolved | 2018-08-28 | 2018-10-04 | 59387 |
DUREZOL | 0.05% | EMULSION | Resolved | 2019-08-13 | 2019-11-07 | 91488 |
DUREZOL | 0.05% | EMULSION | Resolved | 2022-01-12 | 2024-04-05 | 152583 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |